PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. Estimates – FWB:1S70
TradingView · 23 Oct 2026
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire · 02 Oct 2026
Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis
BioBuzz · 02 Oct 2026
H.C. Wainwright reiterates Cartesian Therapeutics stock rating at buy By Investing.com
Investing.com India · 30 Sep 2026
Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis
GlobeNewswire · 29 Sep 2026
Cartesian Therapeutics Unveils Phase 2 Descartes-08 Retreatment Results in Myasthenia Gravis Patients
Kalkine Media · 29 Sep 2026
Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
TradingView · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.